Winnie Kerstens
0000-0003-4933-6448
KU Leuven
13 papers found
Refreshing results…
Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters
FLUIDOT: A Modular Microfluidic Platform for Single‐Cell Study and Retrieval, with Applications in Drug Tolerance Screening and Antibody Mining
Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters
Immunogenicity and efficacy in rodents and non-human primates of a pair of two live-attenuated flavivirus-vectored vaccine candidates with dual rabies/yellow fever, or rabies/Japanese encephalitis activity
Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model
High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium
An innovative microfluidic platform with optical tweezers for screening and retrieval of B cells: its applicability demonstrated by discovering anti-SARS-CoV-2 monoclonal antibodies
Three-Dimensional Visualization of APEX2-Tagged Erg11 in Saccharomyces cerevisiae Using Focused Ion Beam Scanning Electron Microscopy
Towards a better understanding of ERG11 biology in the model organism Saccharomyces cerevisiae and in the opportunistic human pathogen Candida albicans
A Cinderella story: how the vacuolar proteases Pep4 and Prb1 do more than cleaning up the cell’s mass degradation processes
The CYP51s of Saccharomyces cerevisiae and Candida albicans exist as multiple isoforms and might influence the outcome of azole antifungal therapy.
The role of protein kinase A in tolerance to azole drugs in Candida albicans
Bimodal targeting of Erg11 in Candida albicans - The importance of mitochondrial Erg11 in tolerance to azole drugs
Missing publications? Search for publications with a matching author name.